• Return to Headlines

Array Biopharma: 52-Week High Recently Eclipsed (ARRY)

By Nick Russo

Shares of Array Biopharma (NASDAQ:ARRY) traded at a new 52-week high today of $47.22. So far today approximately 1.8 million shares have been exchanged, as compared to an average 30-day volume of 3.5 million shares.

Array Biopharma share prices have moved between a 52-week high of $47.22 and a 52-week low of $12.56 and are now trading 271% above that low price at $46.65 per share. Over the last five market days, the 200-day moving average (MA) has gone up 2.0% while the 50-day MA has advanced 4.0%.

Based on a current price of $46.65, Array Biopharma is currently 53.1% above its average consensus analyst price target of $21.86. The stock should discover initial support at its 50-day moving average (MA) of $25.52 and subsequent support at its 200-day MA of $19.66.

Array BioPharma Inc. is a discovery research company, creates drug candidates. The Company provides drug discovery products and services to create, evaluate, and optimize potential drug candidates in collaboration with pharmaceutical and biotechnology companies.

SmarTrend recommended that subscribers consider buying shares of Array Biopharma on May 21st, 2019 as our proprietary SmarTrend analytics indicated a new Uptrend was in progress when shares hit $24.38. Since that recommendation, shares of Array Biopharma have risen 91.1%. We continue to monitor ARRY for any potential shift so investors can protect gains and will alert SmarTrend subscribers immediately.

Keywords: 52 week high/lows Array BioPharma

Ticker(s): ARRY